A case report of breast cancer recurrence with cystitis: the impact of immune checkpoint inhibitor therapy on the incidence of cystitis.

BACKGROUND: Immune checkpoint inhibitors (ICIs) are essential for advanced breast cancer, particularly triple-negative breast cancer (TNBC) patients. While effective, they may cause immune-related adverse events (irAEs), including rare cases of cysti…

Preview only. Read the full abstract at the source